Lapatinib plus capecitabine compared to capecitabine alone in patients with metastatic HER2-positive breast cancer-evaluation of the quality of life

Abstract

Administration of capecitabine and lapatinib in women with advanced or progressive HER2-positive breast cancer have a positive impact on the prognosis of patients.

Keywords

• Lapatinib
• capecitabin
• breast cancer
• metastasis